Sk Biopharmaceuticals Co., Ltd.

Institute for Basic Science

Sk Holdings Co., Ltd.

Sk Corporation

Joon Heo

Ki-Ho Lee

Yu-Jin Shin

Han-Ju Yi

Cheol-Young Maeng

Jin-Yong Chung

Eun-Hee Chae

Young-Soon Kang

Yunhee Kim

Kiho Lee

Yonggil Kim

Nahmryune Cho

Seonmin Dong

Mi Kyung Ji

Man-Young Cha

Young Sam Kim

Han Ju Yi

Cheol Young Maeng

Coo-Min Chung

Chun-Eung Park

Jin Yong Chung

Young Soon Kang

Eun Hee Chae

Yu Jin Shin

Ki Ho Lee

Yong-Moon Choi

Sangsu Jung

Jin Uk Yoo

Yong-Kil Kim

Jung Yeon Lee

Jung Im Kang

Jong Gil Choi

Okyu Kwon

Mun Seok Jeong

Choonho Ryu

Sung-Yong Seo

Jin-Uk Yoo

Eun-Ah Paek

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: 

Aminocarbonylcarbamate compounds

The present invention relates to a method of determining a routing path in a communication network in which a plurality of logical networks shares a physical network, and more particularly to such a method of determining a routing path of data, in which multiple routing paths from a source node to a destination node are created based on a change in the dynamic state of a plurality of nodes constituting a logical network, and routing costs for the created multiple routing paths are calculated based on a routing registration message received from the plurality of nodes, and a process time transition value and a transmission time transition value shared by the plurality of nodes.

Method of determining routing path based on change in dynamic state of nodes

The present invention relate to a content caching device, and more particularly, to such a content caching device in which the priority of a content requested by a user terminal is calculated based on content usage features such as the number of requests or the latest request interval of the requested content, and the like, the requested content is controlled to be selectively stored in a short-term storage unit based on the calculated priority of the requested content, and among the contents stored in the short-term storage unit, a content needed to be stored for a long time period is controlled to be stored in a separate long-term storage unit based on the storage time of the requested content in the short-term storage unit.

Content caching device for managing contents based on content usage features

The present invention relate to a method for authenticating a low performance device, and more particularly, to a device authenticating method, in which a low performance device such as a smart meter of a smart grid is authenticated in a matrix operation instead of an exponential operation through a homomorphic hash function (HHF) of a non-square matrix M, so that the amount of operations required for authenticating the device can be reduced and the device can be safely authenticated even without a separate certificate authority.

Method for authenticating low performance device

The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal.

Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof

The present invention relates to a novel piperazine derivative or pharmaceutically acceptable salt thereof, a process for preparing the same, a pharmaceutical composition for treating central nervous system diseases comprising an effective amount of the piperazine compound and a method of treating central nervous system (CNS) disorder such as psychosis in a mammal.

Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof

Provided herein are racemic or enantiomerically enriched benzoyl piperidine compounds and pharmaceutically useful salts thereof, pharmaceutical compositions comprising an effective amount of racemic or enantiomerically enriched benzoyl piperidine compounds to treat central nervous system diseases and methods of treating central nervous system diseases in a mammal, in particular psychoses and cognition disorders.

Benzoyl piperidine compounds

Growing community of inventors

Daejeon, South Korea

Joon Heo